Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 18:47:47 - browse：5346

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： The Karikó problem: Lessons for funding basic research

entertainment

WSS

Biden jokes that Republicans may impeach him because inflation is starting to cool down

With Roe v Wade overturned, abortion providers work to adapt

Study points to new risk in gene therapy death of Terry Horgan

Congress extends some pandemic preparedness programs

Behind warning on Apellis’s eye drug lies a conflict of interest

European officials brace for rough respiratory virus season

explore

Wikipedia

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

CRISPR base editing slashes cholesterol levels in monkeys

Supreme Court strikes down use of affirmative action

Biden jokes that Republicans may impeach him because inflation is starting to cool down

ChatGPT in medicine: STAT answers readers' burning questions

VC firm RA Capital starts a new synthetic biology incubator

Medical records are filled with copy

European officials brace for rough respiratory virus season

Novavax promises a turnaround & Lilly roils the obesity market

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

focus

The United States is paying nearly triple for new Covid vaccines

The United States is paying nearly triple for new Covid vaccines

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Flu, Covid vaccination rates decline, new survey data show

Timeline: Special counsel's probe into Trump's handling of classified documents

leisure time

entertainment

focus

knowledge